Endurant Capital Management’s AdaptHealth AHCO Stock Holding History

Endurant Capital Management’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-89,937	Closed	-$818K	–	29
2023 Q3	$818K	Buy	+89,937	New	+$1.08M	0.74%	32
2022 Q2	–	Sell	-248,314	Closed	-$3.98M	–	52
2022 Q1	$3.98M	Buy	248,314 +150,388	+154%	+$2.7M	1.05%	27
2021 Q4	$2.4M	Sell	97,926 -96,960	-50%	-$2.28M	0.58%	37
2021 Q3	$4.54M	Buy	+194,886	New	+$4.71M	1.03%	26
2021 Q2	–	Sell	-399,730	Closed	-$14.7M	–	59
2021 Q1	$14.7M	Buy	399,730 +249,316	+166%	+$8.81M	3.83%	5
2020 Q4	$5.65M	Sell	150,414 -367,963	-71%	-$11.4M	2.04%	19
2020 Q3	$11.3M	Buy	518,377 +447,377	+630%	+$9.39M	3.34%	9
2020 Q2	$1.14M	Sell	71,000 -149,896	-68%	-$2.51M	0.06%	48
2020 Q1	$3.53M	Buy	220,896 +53,038	+32%	+$749K	1.6%	17
2019 Q4	$1.84M	Buy	+167,858	New	+$1.67M	0.58%	35

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Endurant Capital Management's AHCO Position: Q4 2023 in Review

Endurant Capital Management sold out of AdaptHealth (AHCO) in Q4 2023, closing a stake of 89,937 shares — an estimated $818K sold.

Endurant Capital Management first reported a position in AHCO in Q4 2019 and held it in 10 quarters. The position peaked at $14.7M in Q1 2021. 192 funds tracked by Wall St. Rank hold AHCO as of Q4 2023.

Endurant Capital Management reported no remaining AdaptHealth position as of Q4 2023 after selling out during the quarter.
Endurant Capital Management sold 89,937 AdaptHealth shares in Q4 2023, an estimated $818K.
Endurant Capital Management first reported a position in AdaptHealth in Q4 2019 and held it in 10 quarters.
Endurant Capital Management's AdaptHealth position peaked at $14.7M in Q1 2021.
192 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2023.

Based on Endurant Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.